Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy
Open accessThe DOI matches its Crossref record; 115 of the 117 references it cites were found in a registry or an index; 7 of the 61 sources its claims cite were checked for support.
Abstract
Most disorders of steroidogenesis, such as forms of congenital adrenal hyperplasia (CAH) are caused by mutations in genes encoding the steroidogenic enzymes and are often recognized clinically by cortisol deficiency, hyper- or hypo-androgenism, and/or altered mineralocorticoid function. Most steroidogenic enzymes are forms of cytochrome P450. Most P450s, including several steroidogenic enzymes, are microsomal, requiring electron donation by P450 oxidoreductase (POR); however, several steroidogenic enzymes are mitochondrial P450s, requiring electron donation via ferredoxin reductase (FDXR) and ferredoxin (FDX). POR deficiency is a rare but well-described form of CAH characterized by impaired activity of 21-hydroxylase (P450c21, CYP21A2) and 17-hydroxylase/17,20-lyase (P450c17, CYP17A1); more severely affected individuals also have the Antley-Bixler skeletal malformation syndrome and disordered genital development in both sexes, and hence is easily recognized. The 17,20-lyase activity of P450c17 requires both POR and cytochrome b5 (b5), which promote electron transfer. Mutations of POR, b5, or P450c17 can cause selective 17,20-lyase deficiency. In addition to providing electrons to mitochondrial P450s, FDX, and FDXR are required for the synthesis of iron-sulfur clusters, which are used by many enzymes. Recent work has identified FDXR mutations in patients with visual impairment, optic atrophy, neuropathic hearing loss, and developmental delay, resembling the global neurologic disorders seen with mitochondrial diseases. Many of these patients have had life-threatening events or deadly infections, often without an apparent triggering event. Adrenal insufficiency has been predicted in such individuals but has only been documented recently. Neurologists, neonatologists, and geneticists should seek endocrine assistance in evaluating and treating patients with mutations in FDXR.
Overview
CoChat Summary
TL;DR
This paper is a narrative review of “electron transfer” defects in steroidogenesis, focusing on POR, cytochrome b5, FDX1/FDX2, and especially FDXR as causes of CAH-like disease and mitochondriopathy. Its main clinical warning is that severe FDXR deficiency can include potentially lethal adrenal insufficiency, which should be actively evaluated in affected patients.
Key findings
- POR deficiency is a well-established cause of disordered steroidogenesis and skeletal malformations: the review states that >200 POR mutations have been reported in >250 patients, and that more severe mutations cause Antley-Bixler syndrome, while mutations retaining ~20% to 40% activity may cause “nonclassic POR deficiency.”
- Cytochrome b5 deficiency is rare but can cause isolated 17,20-lyase deficiency and methemoglobinemia; the paper notes that most reported cases involved 46,XY DSD, with one 24-year-old woman homozygous for b5 Y35X reported as having normal development and fertility despite methemoglobinemia.
- Human FDXR deficiency had, by 2017–2023, at least 77 patients from >50 families with 59 different biallelic mutations, presenting with optic atrophy, retinal dystrophy, neuropathic hearing loss, developmental delay, movement disorders, and Leigh syndrome; in one hereditary optic neuropathy cohort, 5/434 patients with autosomal disease had FDXR mutations, and all 5 also had deafness.
- The review highlights a newly recognized endocrine consequence of FDXR deficiency: in a recent study, 2 severely affected siblings with FRM had adrenal insufficiency and a steroid pattern suggesting 11-hydroxylase deficiency, and review of prior FRM cases found severe or life-threatening events/infections suggestive of adrenal insufficiency in 20/77 (26%) patients.
Methods
- Narrative review of published literature on electron-transfer proteins required for steroidogenic mitochondrial and microsomal cytochrome P450 enzymes.
- Synthesizes human genetic, biochemical, cell-culture, and animal-model findings for POR, cytochrome b5, FDX1, FDX2, and FDXR.
- Uses reported case series and cohort studies to summarize phenotypes, mutation counts, and endocrine consequences.
Limitations
- Not stated in the paper.
- Evident from the text: this is a brief review, not a new cohort study or systematic review, so the strength of conclusions depends on heterogeneous prior reports.
- Evident from the text: for some genes/disorders the evidence remains incomplete—e.g., no human FDX1 mutation has yet been reported, and studies of steroidogenesis were not done in the reported FDX2 cases.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
7 Valid · 0 Not valid · 26 Not checked · 9 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Mitochondrial, type 1 P450 enzymes receive electrons from NADPH via an electron transfer chain consisting of ferredoxin reductase (FDXR), which is loosely associated with the inner mitochondrial membrane, and ferredoxin (FDX) in the mitochondrial matrix ( Fig. 2B ) ( 1 , 26 ).”
What the sources say
- Partly supportedcites [1] Miller, 2011, The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders, Endocr Rev sourceExperimental — accuracy not yet measured
The Cytochrome P450 and Transport of electrons to P450scc sections support the NADPH → ferredoxin reductase → ferredoxin pathway for mitochondrial type 1 P450 enzymes. The localization is imprecise: the paper describes ferredoxin reductase as associated with or bound to the inner mitochondrial membrane, while it is ferredoxin that may be loosely associated with that membrane or reside in the matrix. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked yetcites [26] Omura, 2006, Mitochondrial P450s, Chem Biol Interact source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Since then, a small number of reports have described b5 deficiency in patients with apparent isolated 17,20-lyase deficiency, sometimes associated with methemoglobinemia ( 11 , 12 , 54 ).”
What the sources say
- Not checked yetcites [11] Kok, 2010, Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X, J Clin Endocrinol Metab source
- Supportedcites [12] Idkowiak, 2012, A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency, J Clin Endocrinol Metab source
The Discussion ("In our three affected siblings we found mild, clinically inapparent methemoglobinemia, in keeping with the findings in the recently reported patient with a CYB5A nonsense mutation (13)... one additional CYB5A mutation has been reported previously, resulting in a 16-bp deletion due to a splice site mutation (37)... significant methemoglobinemia of 12–19%") records exactly the small set of b5-deficiency reports in patients with apparent isolated 17,20 lyase deficiency and their variable methemoglobinemia. The Abstract Context/Conclusion likewise notes the recently described CYB5A nonsense (p.W27X) mutation in a 46,XY DSD patient diagnosed with isolated 17,20 lyase deficiency and states that methemoglobinemia is commonly present with CYB5A mutations, while the Results/Discussion tabulate only these few CYB5A cases among 15 fully worked-up isolated 17,20 lyase deficiency reports. The hedge "sometimes associated with" is weaker than, and therefore compatible with, the source's "commonly present". (LLM, conf=0.85)
- Not checked yetcites [54] Shaunak, 2020, Isolated 17, 20–lyase deficiency secondary to a novel CYB5A variant: comparison of steroid metabolomic findings with published cases provides diagnostic guidelines and greater insight into its biological role, Horm Res Paediatr source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“A very recent study has now shown such adrenal insufficiency in 2 severely affected siblings with FRM, DSD, and hypertension, with a steroid pattern suggesting 11-hydroxylase deficiency ( 111 ).”
What the sources say
- Supportedcites [111] Pignatti, 2024, FDXR variants cause adrenal insufficiency and atypical sexual development, JCI Insight source
The Abstract reports two siblings with FRM, ambiguous genitalia, cortisol deficiency, and androgen excess compatible with 11-hydroxylase deficiency. The Results describe their severe neuropathy, and the Discussion states that the index patients had elevated blood pressure. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Review of the previously published cases of FRM showed that 20/77 (26%) of these patients also had a history of severe, often life-threatening events or deadly infections suggestive of adrenal insufficiency ( 111 ).”
What the sources say
- Supportedcites [111] Pignatti, 2024, FDXR variants cause adrenal insufficiency and atypical sexual development, JCI Insight source
The Results subsection 'Characteristics of reported patients with biallelic FDXR variants pointing at impaired steroidogenesis' states verbatim that a literature review revealed 77 patients with 59 biallelic FDXR mutations and that, when investigating signs/symptoms of potential undiagnosed adrenal insufficiency, a history of severe, often life-threatening events or deadly infections was found in 20 cases (26%). The Discussion reinforces this framing ('adrenal insufficiency might be a fatal, hidden threat to patients with FRM'). No qualifier in the claim is unmet. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This study also showed that the previously reported mice carrying the Fdxr R389Q mutation also had impaired adrenal function, with impaired corticosterone synthesis, indicative of defective FDXR-supported activity of 11β-hydroxylase (CYP11B1).”
What the sources say
- Partly supportedcites [111] Pignatti, 2024, FDXR variants cause adrenal insufficiency and atypical sexual development, JCI Insight sourceExperimental — accuracy not yet measured
The Results section on the mouse model reports decreased serum corticosterone, suggesting reduced FDXR-supported CYP11B1 activity. However, both that section and the Methods identify the mutation as Fdxr R389W, not R389Q. (LLM, conf=0.88)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
7 more claims
Create a free account to see all 42 claims and to verify the 54 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Another study screened 2186 patients with hereditary optic neuropathy: 1126 had apparent mitochondrial inheritance, with mitochondrial defects found in 199, and 1680 had apparent autosomal disease, with mutations found in 451.”
Reported 2186 · recomputed 2806
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Only 3 steroidogenic P450 enzymes, the cholesterol side-chain cleavage enzyme, P450scc (CYP11A1), 11β-hydroxylase, P450c11β (CYP11B1), and aldosterone synthase, P450c11AS (CYP11B2), reside in mitochondria and require electron donation from FDX and FDXR ( Fig. 1 ).”
“Among human steroidogenic enzymes, 5 are type 1 P450s: P450scc, P450c11β, P450c11AS, vitamin D 1α-hydroxylase (P450c1α, CYP27B1), and vitamin D 24-hydroxylase (P450c24, CYP24A1).”
Citations
Cites
1 retracted
Retracted: CYP4A22 loss-of-function causes a new type of vitamin D–dependent rickets (VDDR1C)
Duan, X., Zhang, Y., & Xu, T. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae084 · Cited by 6
RetractedFriedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationWang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationEarly steps in steroidogenesis: intracellular cholesterol trafficking
Miller, W. L., & Bose, H. S. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r016675 · Cited by 554
Self-citationCytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citationHuman cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
Self-citationThe many roles of cytochrome b5
Schenkman, J. B., & Jansson, I. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00327-3 · Cited by 455
Zhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Self-citationMechanisms of Cytochrome P450-Catalyzed Oxidations
Guengerich, F. P. (2018) · ACS Catalysis · doi:10.1021/acscatal.8b03401 · Cited by 453
Sheftel, A. D., Stehling, O., Pierik, A. J., Elsässer, H.-P., Mühlenhoff, U., Webert, H., Hobler, A., Hannemann, F., Bernhardt, R., & Lill, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004250107 · Cited by 406
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
Self-citationIron–sulfur cluster biogenesis and trafficking in mitochondria
Braymer, J. J., & Lill, R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.787101 · Cited by 389
Rapid regulation of steroidogenesis by mitochondrial protein import
Bose, H. S., Lingappa, V. R., & Miller, W. L. (2002) · Nature · doi:10.1038/417087a · Cited by 357
Self-citationHuang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
Self-citationBiogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease
Rouault, T. A. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009019 · Cited by 331
Minireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Self-citationThe genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
Self-citationGilbert, L. I. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.003 · Cited by 300
Bridges, A., Gruenke, L., Chang, Y.-T., Vakser, I. A., Loew, G., & Waskell, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.17036 · Cited by 287
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
Self-citationEcdysone response genes govern egg chamber development during mid-oogenesis in Drosophila
Buszczak, M., Freeman, M. R., Carlson, J. R., Bender, M., Cooley, L., & Segraves, W. A. (1999) · Development · doi:10.1242/dev.126.20.4581 · Cited by 276
VOUTILAINEN, R., TAPANAINEN, J., CHUNG, B.-C., MATTESON, K. J., & MILLER, W. L. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-1-202 · Cited by 253
Self-citationWatari, H., Arakane, F., Moog-Lutz, C., Kallen, C. B., Tomasetto, C., Gerton, G. L., Rio, M.-C., Baker, M. E., & Strauss, J. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8462 · Cited by 247
Haploinsufficiency of TNXB Is Associated with Hypermobility Type of Ehlers-Danlos Syndrome
Zweers, M. C., Bristow, J., Steijlen, P. M., Dean, W. B., Hamel, B. C., Otero, M., Kucharekova, M., Boezeman, J. B., & Schalkwijk, J. (2003) · The American Journal of Human Genetics · doi:10.1086/376564 · Cited by 242
Stehling, O., & Lill, R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011312 · Cited by 227
Steroidogenesis: Unanswered Questions
Miller, W. L. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.09.002 · Cited by 226
Self-citationShen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225
Mochel, F., Knight, M. A., Tong, W.-H., Hernandez, D., Ayyad, K., Taivassalo, T., Andersen, P. M., Singleton, A., Rouault, T. A., Fischbeck, K. H., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.012 · Cited by 210
Mammalian iron-sulphur proteins: novel insights into biogenesis and function
Rouault, T. A. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3909 · Cited by 201
Yamazaki, H., Johnson, W. W., Ueng, Y.-F., Shimada, T., & Guengerich, F. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27438 · Cited by 194
Baker, B. Y., Lin, L., Kim, C. J., Raza, J., Smith, C. P., Miller, W. L., & Achermann, J. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1565 · Cited by 194
Self-citationShi, Y., Ghosh, M., Kovtunovych, G., Crooks, D. R., & Rouault, T. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.002 · Cited by 194
Formation and Properties of [4Fe-4S] Clusters on the IscU Scaffold Protein
Chandramouli, K., Unciuleac, M.-C., Naik, S., Dean, D. R., Huynh, B. H., & Johnson, M. K. (2007) · Biochemistry · doi:10.1021/bi6026659 · Cited by 191
Otto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189
Laue, K., Pogoda, H.-M., Daniel, P. B., van Haeringen, A., Alanay, Y., von Ameln, S., Rachwalski, M., Morgan, T., Gray, M. J., Breuning, M. H., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.09.015 · Cited by 188
Geller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183
Self-citationCherradi, N., Rossier, M. F., Vallotton, M. B., Timberg, R., Friedberg, I., Orly, J., Wang, X. J., Stocco, D. M., & Capponi, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7899 · Cited by 175
Lin, D. (1993) · Endocrinology · doi:10.1210/en.132.6.2498 · Cited by 175
Self-citationYanagibashi, K., & Hall, P. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83930-3 · Cited by 171
Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17
Pandey, A. V., & Miller, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414673200 · Cited by 165
Self-citationCoghlan, V. M., & Vickery, L. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55106-1 · Cited by 160
Alternative FeS cluster ligands: tuning redox potentials and chemistry
Bak, D. W., & Elliott, S. J. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.12.015 · Cited by 160
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Congenital Methemoglobinemia with a Deficiency of Cytochrome B5
Hegesh, E., Hegesh, J., & Kaftory, A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141206 · Cited by 150
Outlining the Complex Pathway of Mammalian Fe-S Cluster Biogenesis
Maio, N., & Rouault, T. A. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.02.001 · Cited by 149
Cai, K., Tonelli, M., Frederick, R. O., & Markley, J. L. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b00447 · Cited by 148
New players in the regulation of ecdysone biosynthesis
Huang, X., Warren, J. T., & Gilbert, L. I. (2008) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60001-6 · Cited by 143
Human adrenodoxin: cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells
Picado-Leonard, J., Voutilainen, R., Kao, L. C., Chung, B. C., Strauss, J. F., & Miller, W. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69061-1 · Cited by 140
Self-citationDomain Motion in Cytochrome P450 Reductase
Ellis, J., Gutierrez, A., Barsukov, I. L., Huang, W.-C., Grossmann, J. G., & Roberts, G. C. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054304 · Cited by 140
Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17
Pandey, A. V., Mellon, S. H., & Miller, W. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209527200 · Cited by 137
Self-citationMolecular cloning of cDNA for vitamin D3 25‐hydroxylase from rat liver mitochondria
Usui, E., Noshiro, M., & Okuda, K. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80172-f · Cited by 123
Okamura, T., John, M. E., Zuber, M. X., Simpson, E. R., & Waterman, M. R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5705 · Cited by 121
SU, P., RENNERT, H., SHAYIQ, R. M., YAMAMOTO, R., ZHENG, Y.-M., ADDYA, S., STRAUSS, J. F., & AVADHANI, N. G. (1990) · DNA and Cell Biology · doi:10.1089/dna.1990.9.657 · Cited by 120
Valentine, R. C. (1964) · Bacteriological Reviews · doi:10.1128/br.28.4.497-517.1964 · Cited by 120
The dare gene: steroid hormone production, olfactory behavior, and neural degeneration in Drosophila
Freeman, M. R., Dobritsa, A., Gaines, P., Segraves, W. A., & Carlson, J. R. (1999) · Development · doi:10.1242/dev.126.20.4591 · Cited by 119
Omura, T. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.06.008 · Cited by 117
Olsson, A., Lind, L., Thornell, L.-E., & Holmberg, M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn057 · Cited by 115
Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
Sahakitrungruang, T., Tee, M. K., Blackett, P. R., & Miller, W. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1828 · Cited by 111
Self-citationMitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease
Isaya, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00029 · Cited by 109
Idkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Clinical manifestation and a new ISCU mutation in iron–sulphur cluster deficiency myopathy
Kollberg, G., Tulinius, M., Melberg, A., Darin, N., Andersen, O., Holmgren, D., Oldfors, A., & Holme, E. (2009) · Brain · doi:10.1093/brain/awp152 · Cited by 104
Bose, H. S., Whittal, R. M., Huang, M.-C., Baldwin, M. A., & Miller, W. L. (2000) · Biochemistry · doi:10.1021/bi000911l · Cited by 101
Self-citationSolish, S. B., Picado-Leonard, J., Morel, Y., Kuhn, R. W., Mohandas, T. K., Hanukoglu, I., & Miller, W. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7104 · Cited by 101
Self-citationLi, K., Tong, W.-H., Hughes, R. M., & Rouault, T. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600582200 · Cited by 98
Paul, A., Drecourt, A., Petit, F., Deguine, D. D., Vasnier, C., Oufadem, M., Masson, C., Bonnet, C., Masmoudi, S., Mosnier, I., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.007 · Cited by 95
Deleterious mutation in FDX1L gene is associated with a novel mitochondrial muscle myopathy
Spiegel, R., Saada, A., Halvardson, J., Soiferman, D., Shaag, A., Edvardson, S., Horovitz, Y., Khayat, M., Shalev, S. A., Feuk, L., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.269 · Cited by 89
Consequences of POR mutations and polymorphisms
Miller, W. L., Agrawal, V., Sandee, D., Tee, M. K., Huang, N., Choi, J. H., Morrissey, K., & Giacomini, K. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.10.022 · Cited by 88
Self-citationFukami, M., Hasegawa, T., Horikawa, R., Ohashi, T., Nishimura, G., Homma, K., & Ogata, T. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000195825.31504.28 · Cited by 79
Maio, N., Jain, A., & Rouault, T. A. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.11.014 · Cited by 78
Giordano, S., Kaftory, A., & Steggles, A. (1994) · Human Genetics · doi:10.1007/bf00202825 · Cited by 70
Tee, M. K., & Miller, W. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.460048 · Cited by 69
Self-citationMolten Globule Structure and Steroidogenic Activity of N-218 MLN64 in Human Placental Mitochondria
Tuckey, R. C., Bose, H. S., Czerwionka, I., & Miller, W. L. (2004) · Endocrinology · doi:10.1210/en.2003-1034 · Cited by 65
Self-citationcAMP post-transcriptionally diminishes the abundance of adrenodoxin reductase mRNA
Brentano, S. T., Black, S. M., Lin, D., & Miller, W. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4099 · Cited by 62
Self-citationCloning and sequence of the human adrenodoxin reductase gene
Lin, D., Shi, Y. F., & Miller, W. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8516 · Cited by 61
Self-citationTenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome
Miller, W. L., & Merke, D. P. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481911 · Cited by 61
Self-citationExome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders
Fairfield, H., Srivastava, A., Ananda, G., Liu, R., Kircher, M., Lakshminarayana, A., Harris, B. S., Karst, S. Y., Dionne, L. A., Kane, C. C., et al. (2015) · Genome Research · doi:10.1101/gr.186882.114 · Cited by 61
Peng, Y., Shinde, D. N., Valencia, C. A., Mo, J.-S., Rosenfeld, J., Truitt Cho, M., Chamberlin, A., Li, Z., Liu, J., Gui, B., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx377 · Cited by 60
Cloning and structure of the human adrenodoxin gene
CHANG, C.-Y., WU, D.-A., LAI, C.-C., MILLER, W. L., & CHUNG, B.-C. (1988) · DNA · doi:10.1089/dna.1988.7.609 · Cited by 55
Self-citationThe top 10 most frequently involved genes in hereditary optic neuropathies in 2186 probands
Rocatcher, A., Desquiret‐Dumas, V., Charif, M., Ferré, M., Gohier, P., Mirebeau‐Prunier, D., Verny, C., Miléa, D., Lenaers, G., HON Collaborators Group, et al. (2022) · Brain · doi:10.1093/brain/awac395 · Cited by 54
Molecular cloning and sequence analysis of human placental ferredoxin
Mittal, S., Zhu, Y., & Vickery, L. E. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90303-7 · Cited by 52
A novel complex neurological phenotype due to a homozygous mutation in FDX2
Gurgel‐Giannetti, J., Lynch, D. S., de Paiva, A. R. B., Lucato, L. T., Yamamoto, G. L., Thomsen, C., Basu, S., Freua, F., Giannetti, A. V., Della‐Ripa, B., et al. (2018) · Brain · doi:10.1093/brain/awy172 · Cited by 51
Expression and characterization of human mitochondrial ferredoxin reductase in Escherichia coli
Brandt, M. E., & Vickery, L. E. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90749-m · Cited by 47
Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis
Duggal, R., Liu, Y., Gregory, M. C., Denisov, I. G., Kincaid, J. R., & Sligar, S. G. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.043 · Cited by 45
Integrated analysis of the molecular pathogenesis of FDXR-associated disease
Slone, J. D., Yang, L., Peng, Y., Queme, L. F., Harris, B., Rizzo, S. J. S., Green, T., Ryan, J. L., Jankowski, M. P., Reinholdt, L. G., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2637-3 · Cited by 42
The human liver and reticulocyte cytochrome b5 mRNAs are products from a single gene
Giordano, S. J., & Steggles, A. W. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91776-9 · Cited by 41
Griffin, A., Parajes, S., Weger, M., Zaucker, A., Taylor, A. E., O'Neil, D. M., Müller, F., & Krone, N. (2016) · Endocrinology · doi:10.1210/en.2015-1480 · Cited by 41
Morel, Y., Picado-Leonard, J., Wu, D., Chang, C. Y., Mohandas, T. K., Chung, B., & Miller, W. L. (1988) · PubMed · Cited by 39
Self-citationBiallelic mutations in FDXR cause neurodegeneration associated with inflammation
Slone, J., Peng, Y., Chamberlin, A., Harris, B., Kaylor, J., McDonald, M. T., Lemmon, M., El-Dairi, M. A., Tchapyjnikov, D., Gonzalez-Krellwitz, L. A., et al. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0515-y · Cited by 37
Cytochrome b5 modulates multiple reactions in steroidogenesis by diverse mechanisms
Storbeck, K., Swart, A. C., Fox, C.-L., & Swart, P. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.024 · Cited by 36
A novel de novo dominant mutation in ISCU associated with mitochondrial myopathy
Legati, A., Reyes, A., Berti, C. C., Stehling, O., Marchet, S., Lamperti, C., Ferrari, A., Robinson, A. J., Mühlenhoff, U., Lill, R., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104822 · Cited by 35
Clinical and genetic aspects of defects in the mitochondrial iron–sulfur cluster synthesis pathway
Vanlander, A. V., & Coster, R. V. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1550-z · Cited by 30
Duggal, R., Denisov, I. G., & Sligar, S. G. (2018) · FEBS Letters · doi:10.1002/1873-3468.13153 · Cited by 27
Steroidogenic electron-transfer factors and their diseases
Miller, W. L. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142154.077 · Cited by 24
Self-citationOakes, J., Li, N., Wistow, B., Griffin, A., Barnard, L., Storbeck, K., Cunliffe, V. T., & Krone, N. P. (2019) · Endocrinology · doi:10.1210/en.2019-00068 · Cited by 23
Stenton, S. L., Piekutowska‐Abramczuk, D., Kulterer, L., Kopajtich, R., Claeys, K. G., Ciara, E., Eisen, J., Płoski, R., Pronicka, E., Malczyk, K., et al. (2020) · Human Mutation · doi:10.1002/humu.24160 · Cited by 23
Thomas, J. L., & Bose, H. S. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.018 · Cited by 22
Expanding the FDXR -Associated Disease Phenotype: Retinal Dystrophy Is a Recurrent Ocular Feature
Jurkutė, N., Shanmugarajah, P. D., Hadjivassiliou, M., Higgs, J. E., Vojcic, M., Horrocks, I. A., Nadjar, Y., Touitou, V., Lenaers, G., Poh, R., et al. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.6.2 · Cited by 19
Leung, M. T., Cheung, H. N., Iu, Y. P. H., Choi, C. H., Tiu, S. C., & Shek, C. C. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz016 · Cited by 18
Human ferredoxin-2 displays a unique conformational change
Qi, W., Li, J., & Cowan, J. A. (2013) · Dalton Trans. · doi:10.1039/c2dt32018e · Cited by 17
Refining a steroidogenic model: an analysis of RNA-seq datasets from insect prothoracic glands
Moulos, P., Αλεξανδράτος, Α., Nellas, I., & Dedos, S. (2018) · BMC Genomics · doi:10.1186/s12864-018-4896-2 · Cited by 14
Yang, C., Zhang, Y., Li, J., Song, Z., Yi, Z., Li, F., Xue, J., Zhang, V. W., & Wang, C. (2021) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10104 · Cited by 14
Song, S., Xu, K., & Zhang, C. (2021) · International Journal of Ophthalmology · doi:10.18240/ijo.2021.11.22 · Cited by 13
Mammalian mitochondrial iron–sulfur cluster biogenesis and transfer and related human diseases
Wenxin, Z., Xu, L., Hongting, Z., & Li, K. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.200038 · Cited by 12
Yi, S., Zheng, Y., Yi, Z., Wang, Y., Jiang, Y., Ouyang, J., Li, S., Xiao, X., Sun, W., Wang, P., et al. (2023) · Genes · doi:10.3390/genes14040952 · Cited by 12
FDXR variants cause adrenal insufficiency and atypical sexual development
Pignatti, E., Slone, J., Gómez Cano, M. Á., Campbell, T. M., Vu, J., Sauter, K.-S., Pandey, A. V., Martínez-Azorín, F., Alonso-Riaño, M., Neilson, D. E., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.179071 · Cited by 12
Masnada, S., Previtali, R., Erba, P. A., Beretta, E., Camporesi, A., Chiapparini, L., Doneda, C., Iascone, M. R., Sartorio, M. U. A., Spaccini, L., et al. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06790-0 · Cited by 10
Shaunak, M., Taylor, N. F., Hunt, D., & Davies, J. H. (2020) · Hormone Research in Paediatrics · doi:10.1159/000512372 · Cited by 6
Campbell, T., Slone, J. D., Metzger, H., Liu, W., Sacharow, S. J., Yang, A., Moosajee, M., Morgia, C. L., Carelli, V., Palombo, F., et al. (2023) · Genetics in Medicine Open · doi:10.1016/j.gimo.2023.100841 · Cited by 6
[Primary structure of hepatoredoxin from bovine liver mitochondria].
Vl, C., Lapko, V. N., Adamovich, T. B., Nm, K., & Ag, L. (1986) · PubMed · Cited by 5
P450 oxidoreductase deficiency
Flück, C. E., Velazquez, M. N. R., & Pandey, A. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00012-5 · Cited by 4
Self-citation
Cited by
Nanoparticles with curcumin and piperine modulate steroid biosynthesis in prostate cancer
Yakubu, J., Natsaridis, E., du Toit, T., Barata, I. S., Tagit, O., & Pandey, A. V. (2025) · Scientific Reports · doi:10.1038/s41598-025-98102-z · Cited by 32
Self-citationThirty years of StAR gazing. Expanding the universe of the steroidogenic acute regulatory protein
Miller, W. L. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0310 · Cited by 22
Self-citationLane, T. R., Vignaux, P. A., Harris, J. S., Snyder, S. H., Urbina, F., & Ekins, S. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c04054 · Cited by 10
Baptista, C., Esteves, F., Fallowfield, J. A., Kendall, T. J., Nelson, L. J., & Kranendonk, M. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01202-y · Cited by 8
A Novel POR G88S Mutation Causes Severe PORD and Establishes a Critical Pharmacogenomic Risk Profile
Velazquez, M. N. R., Dacal, J. L., Jørgensen, F. S., Sanguineti, N., Sharma, K., Marino, R. M., Garrido, N. P., Vaiani, E., Ramírez, P., Scaglia, P. A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf630 · Cited by 4
Self-citation
Metadata
- Authors
- Miller, W. L., Pandey, A. V., & Flück, C. E.
- Affiliations
- University of California, San Francisco (US)
- University of Bern (CH)
- Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern , Bern 3010 ,
- Corresponding author
- Miller, Walter L
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2024-11-22
- Volume
- 110
- Issue
- 3
- Pages
- e574-e582
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC11834722
- OpenAlex
- W4404642664
- Cited by
- 17
- References
- 117
- Citations by year
- 2026: 9 · 2025: 8
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Open Access CRIS of the University of Bern
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- steroidogenesis, congenital adrenal hyperplasia, P450 oxidoreductase deficiency, ferredoxin reductase, ferredoxin, cytochrome b5, 17,20-lyase deficiency, CYP17A1, CYP21A2, mitochondrial disease, mitochondrial neurogastrointestinal encephalomyopathy, adrenal insufficiency, mitochondrial DNA mutations, iron-sulfur clusters
- MeSH terms
- Adrenal Hyperplasia, Congenital, Cytochrome P-450 Enzyme System, Electron Transport, Humans, Mitochondria, Steroid 17-alpha-Hydroxylase, Steroids, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.